![腾博会官网·[中国]-诚信为本,专业服务!
制药英文站](http://zhengzhoujiaobanji.com/userfiles/images/banner/sinologo.png)
Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.04.25
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.04.22
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO THE COOPERATIVE AGREEMENT IN RELATION TO COMBINATION THERAPIES2022.04.21
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.04.21
-
VOLUNTARY ANNOUNCEMENT - CATEGORY I ANTI-TUMOR INNOVATIVE DRUG "TQB2930" OBTAINED APPROVAL FOR CLINICAL TRIAL2022.04.20
-
VOLUNTARY ANNOUNCEMENT - “ANLOTINIB HYDROCHLORIDE CAPSULES” OBTAINED APPROVAL FOR THE FIFTH INDICATION2022.04.19
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.04.14
-
NEXT DAY DISCLOSURE RETURN2022.04.11